Pulmonx Corporation
LUNG
$4.52
-$0.27-5.64%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 7.31% | 6.75% | 4.37% | 0.38% | -3.26% |
| Total Depreciation and Amortization | -3.55% | -9.78% | 43.96% | -3.03% | 2.31% |
| Total Amortization of Deferred Charges | 3,585.42% | 3,835.56% | 2,015.22% | 12.50% | -14.29% |
| Total Other Non-Cash Items | -3.71% | -0.10% | 13.24% | 22.11% | 25.46% |
| Change in Net Operating Assets | 33.42% | 1.29% | -19.69% | 21.22% | 63.53% |
| Cash from Operations | 16.15% | 14.66% | 15.57% | 13.91% | 16.58% |
| Capital Expenditure | -79.31% | -96.17% | -182.81% | -46.87% | 38.77% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1,676.92% | 172.39% | -893.75% | -239.66% | 58.72% |
| Cash from Investing | 970.75% | 3,014.29% | -454.23% | -358.14% | 52.50% |
| Total Debt Issued | -- | -100.00% | -100.00% | -100.00% | -- |
| Total Debt Repaid | -1.06% | -3.33% | -3.33% | -8.05% | -8.05% |
| Issuance of Common Stock | -2.41% | -12.90% | -22.10% | -17.73% | -42.23% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -93.63% | -93.86% | -93.44% | -92.93% | 784.66% |
| Foreign Exchange rate Adjustments | 123.53% | -843.18% | -117.65% | -57.93% | -76.55% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 30.58% | -81.13% | -90.38% | -114.51% | 61.10% |